A STUDY OF DRUG PRESCRIBING PATTERN AND COST ANALYSIS AMONG DIABETIC PATIENTS IN A TERTIARY CARE TEACHING INSTITUTE IN NORTH INDIA’
Abstract
Diabetes mellitus is a chronic metabolic disorder associated with significant morbidity and mortality due to diabetic complications and other co-morbid conditions. Therefore, other drugs are also used commonly with antidiabetic drugs for the treatment of diabetic patients. A prescription is a written advice, mentioning the drugs and other instructions to a pharmacist to dispense the drugs properly to treat the disease. It becomes necessary to write the drugs and other parameters in a candid, concrete and clear manner on the prescription slip. It has been observed that prescriptions are generally vague which lead to misinterpretations and thereby resulting in failure of drug therapy, drug-drug interactions, overuse or underuse of drug and adverse drug reactions. WHO has set quality and quantity indicators to evaluate the use of drugs to be used in the hospitals/dispensaries. Prescription slips were randomly collected from the diabetic patients visiting the OPDs of the Guru Gobind Singh Hospital attached to Medical College, Faridkot, for analysis and evaluation. Prescriptions slips were taken from the patients after taking written consent and analyzed for quality and quantity prescriber indicators recommended by WHO. A total of 366 prescriptions were collected and analyzed for drugs used in diabetic patients. Average number of drugs prescribed is 4.98. The most commonly prescribed drugs were Oral antidiabetic agents, CVS related (antihypertensive, nitrate, antiplatelet, etc.), vitamins and minerals, insulin, GIT related drugs, lipid lowering drugs, antimicrobial, CNS related and NSAIDs and their percentages were 20.55%, 26.97%, 22.20%, 7.8%, 6.57%, 5.86%, 5.75%, 2.63% and 1.48% respectively. All the drugs were prescribed by non-generic (Trade) names, which included 31.36% drugs from the Essential Drugs List. Oral forms prescribed were 85.85% and injectable were 14.15% (insulin 7.8% and other injectable 6.35%).The average cost of the oral antidiabetic agent per day per prescription was ₹7.95/- and this cost increased to ₹10.15/- with addition of CVS related drugs, ₹17.23/- with vitamins& minerals and ₹10.57/- with lipid lowering agents and it was seen that if a patient was prescribed all these drugs then the average cost of the treatment got raised to ₹45/- (approx.) or $ 0.82 USD per day per prescription. There is a high tendency and frequency to prescribe more than two drugs but less used from the essential drugs list for the treatment of the diabetesand other co-morbid conditions. Most of the drugs prescribed were cardiovascular related drugs and multivitamins along with oral antidiabetic drugs. There is an urgent need to develop the prescription writing skills for budding doctors regarding the use of Essential Drugs List to reduce the cost of treatment. Key words: Prescription audit, prescribing indicators, Essential Medicine List (EML), Co-morbid conditions
Downloads
References
Badyal D. Practical Manual of Pharmacology. 1sted.New Delhi:
Jaypee Brothers Medical Publishers (P) Ltd; 2008. P. 159-161.
Ramesh K V, Shenoy A, Chowta M N. Practical Pharmacology
For MBBS. 1sted, New Delhi: Arya Publishing Company; 2006.
P.106-107.
Powers AC. Diabetes Mellitus. In: Kasper DL, Fauci AS, Longo
DL, Braunwald E, Hauser SL, Jameson JL. Harrison’s Princples
of Internal Medicine. 17thed. New York: McGraw-Hill Medical
Publishing division; 2008.P.2275-2304
World Health Organization. Development and Updation of the
diabetes Mellitus ATLAS of India. Available at :
http:www.whoindia.org/Link Files/
NMH_Resources_Diabetes_atlas.pdf.Accessed on 1 April 2011.
Wild S, Roglic G, Green A, Sicree R, King J, Global prevalence
of diabetes-Estimates for the year 2000 and projections for 2030,
Diabetes Care. 2004, 27, 1047-1053.
World Health Organization .Teachers Guide to Good Prescribing.
World Health Organization Department of Essential Drugs and
Medicine Policy. Geneva: World Health Organization, Geneva:
World Health Organization. Introduction to Drug Utilization
Research. World Health Organization. Geneva: 2003.
Upadhyay DK, Palaian S, Ravi Shankar P, Mishara P, Sah A K,
Journal of Medicine and Diagnostic Research, Aug. 2007, 1(4),
-255.
Enwere OO, Salako BL, Falade CO, Prescription at a Diabetic
Clinic in Ibadan, Nigeria: A Report, Annals of Ibadan
Postgraduate Medicine. Dec. 2004,Vol.4 (2),35-39.
Dhwani K, Sachdeva P, Prescribing Trends of Antidiabetics in
Diabetic Patients And Hypertensive Diabetic Patients In An Urban
Secondary Care Hospital. International Journal of Pharmaceutical
and Biological Archives, 2010, 1(2), 249-245.
World Health Organization. WHO Model List of Essential
Medicines. 17th
ed. World Health Organization. Geneva: 2011
march. Available at
http:www.who.int/medicines/publications/essentialmedicine/en/in
dex.html assessed on 6/02/2013.
Tripathi KD. Essentials of Pharmacology. 6thed. New Delhi:
Jaypee Brothers Medical Publishers (P) Ltd; 2008.P. 903-907
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).